Skip to main content
Medicover logo

Medicover — Investor Relations & Filings

Ticker · MCOV ISIN · SE0009778848 LEI · 5493000E9BUOYMOW2K53 ST Human health and social work activities
Open in API
Filings indexed 285 across all filing types
Latest filing 2024-04-30 Declaration of Voting R…
Country SE Sweden
Listing ST MCOV

About Medicover

https://www.medicover.com/

Medicover is an international healthcare and diagnostic services provider. The company operates through two main divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division delivers a broad range of medical care, including primary care, specialist consultations, and hospital treatment. The Diagnostic Services division offers a comprehensive array of laboratory tests, from routine to advanced diagnostics, serving a wide network of clients. Committed to patient-centric care, Medicover focuses on quality, accessibility, and affordability by investing in modern medical technology and innovation. Its core mission is to improve and sustain the health and wellbeing of its customers.

Recent filings

Filing Released Lang Actions
Antal aktier och röster i Medicover
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a 'Pressmeddelande' (Press Release) dated April 30, 2024, titled 'ANTAL AKTIER OCH RÖSTER I MEDICOVER' (Number of Shares and Votes in Medicover). It explicitly details a change in the total number of shares and votes following a conversion of A-shares to B-shares. This type of announcement, which reports on changes in the capital structure (specifically share count and voting rights), aligns most closely with the 'Share Issue/Capital Change' definition (SHA). Although it mentions voting rights, the primary focus is the total share count change, making SHA a better fit than DVA (which focuses on voting results from a meeting). It is not a full report, so RPA/RNS is less specific. Confidence is high due to the explicit nature of the content regarding share structure.
2024-04-30 Swedish
Kommuniké från årsstämma i Medicover AB (publ)
AGM Information Classification · 1% confidence The document is explicitly titled "KOMMUNIKÉ FRÅN ÅRSSTÄMMA I MEDICOVER AB (PUBL)" which translates to 'COMMUNIQUÉ FROM THE ANNUAL GENERAL MEETING OF MEDICOVER AB (PUBL)'. The content details decisions made at the AGM regarding board elections, remuneration, approval of the annual report, dividend declaration, approval of the remuneration report, and adoption of guidelines/incentive programs. This content directly relates to the proceedings and outcomes of an Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R).
2024-04-26 Swedish
Bulletin from annual general meeting in Medicover AB (publ)
AGM Information Classification · 1% confidence The document is explicitly titled "BULLETIN FROM ANNUAL GENERAL MEETING IN MEDICOVER AB (PUBL)" and details the resolutions passed at the AGM held on April 26, 2024. It covers the election of the board and auditor, approval of fees, adoption of annual accounts, dividend declaration, approval of remuneration reports, and authorizations regarding share programs and repurchases. These are the core outcomes and announcements resulting from an Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R).
2024-04-26 English
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for the period January–March 2024 for Medicover. It contains detailed financial statements, including income statements, segment reporting, key performance indicators (EBIT, EBITDA, revenue), and management commentary on business performance. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-04-26 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 1% confidence The document is titled 'INTERIM REPORT JANUARY–MARCH 2024' and contains comprehensive financial statements, including revenue, operating profit, EBITDA, and net profit for the first quarter of 2024 compared to the same period in 2023. It also includes a CEO statement, detailed divisional performance analysis, and operational metrics. As it provides substantive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2024
2024-04-26 English
Annual Report (ESEF) 2023
Annual Report (ESEF) Classification · 1% confidence FY 2023
2024-03-27 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.